Cameron Herberts, Phd Email & Phone Number

Vancouver, BC, CA

Vancouver, British Columbia, Canada

• I lead clinical genomics studies to accelerate personalized management strategies for men with lethal prostate cancer. Highlights:
• Led translational analyses for biomarker research in late phase clinical trials. Provided scientific strategy and full lifecycle project management across multiple synchronous studies culminating in 8 high-impact.
• Steered an international network of collaborations with KOL clinical trialists and basic/translational scientists. Developed and executed experimental plans, coordinate material transfer, and regularly presented at.
• Wrote translational Statistical Analysis Plans and executed clinical/biomarker analyses for two first-in-field ctDNA-informed clinical trials. Interfaced with study chairs and senior leadership to align.
• Trained and mentored cross-functional teams of 3-6 laboratory and data scientists, trainees, and clinicians. Headed weekly meetings to define interim goals, establish timelines, and strategically manage team dynamics.
• Spearheaded development of a novel point-of-care machine learning tool to optimize patient biomarker testing and streamline clinical decision-making (available at ctdna.org)—now integrated into a pII clinical trial.

Vancouver, British Columbia, Canada

• Performed custom multimodal reverse-translational analyses in clinical trial cohorts and real-world biobanks using Shell and Python, variably integrating ctDNA/tissue genomic and epigenomic (ChIP-seq, methylation-seq).
• Facilitated technical validation and deployment of a ctDNA companion diagnostic for BRCA1/2 screening for a nationwide targeted drug access program (BioPharma collaboration).

Tampere, Pirkanmaa, Finland

• Oversaw end-to-end development of novel published ctDNA cancer phenotyping algorithms for discovery of drug resistance mechanisms and individualized patient monitoring (e.g. fragmentomic profiling and plasma cell-free.
• Developed new subclonal reconstruction bioinformatic algorithms to quantify tumour population dynamics in response to therapy using ctDNA whole-genome sequencing (WGS).
• Independently funded by a competitive federal award: CIHR Michael Smith Foreign Study Supplement ($6,000 CAD).

Vancouver, British Columbia, Canada

PhD program rotation with Dr. Martin Hirst's lab. Wrote a peak-calling routine to perform a harmonized re-analysis of a large pan-cancer ChIP-Seq dataset (multiple markers).

Vancouver, British Columbia, Canada

PhD program rotation with Dr. Gregg Morin's lab. Constructed a pipeline for bulk RNA-Seq batch correction and differential expression analysis (DESeq2+edgeR); applied to CDK13 knockout and WT cell-lines to characterize downstream cellular effects.

Stuttgart Area, Germany

Doctor Of Philosophy - Phd, Clinical Cancer Genomics And Bioinformatics

PhD Candidate in Dr. Alexander Wyatt's laboratory, supported by a CIHR Frederick Banting and Charles Best Doctoral Award ($105,000)..

Bachelor Of Science - Bs, Honours Biophysics

Activities and Societies: Biophysics Student Society Executive; UBC Orientations; UBC Biomedical Engineering Student Team; UBC Physics &.